All results
1 results
-
Biohaven SMA
This trial will study the efficacy and safety of taldefgrobep alfa as an adjunctive therapy for participants who are already taking a stable dose of nusinersen…
- Ages
- 4 Years - 21 Years
- Sexes
- All